File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.cclet.2019.07.004
- Scopus: eid_2-s2.0-85069575632
- WOS: WOS:000482249800003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Establishing the structure-activity relationship of teixobactin
Title | Establishing the structure-activity relationship of teixobactin |
---|---|
Authors | |
Keywords | Teixobactin Antibacterial Peptide synthesis Structure-activity relationship Cyclic peptides |
Issue Date | 2019 |
Publisher | Elsevier Ltd for Chinese Chemical Society. The Journal's web site is located at http://www.chinchemlett.com.cn |
Citation | Chinese Chemical Letters, 2019, v. 30 n. 8, p. 1468-1480 How to Cite? |
Abstract | In 2015, a new antimicrobial peptide agent was discovered, termed teixobactin. Over the past few years, the structure-activity relationship of teixobactin has been extensively studied. Here, the updated studies have been summarized to provide structure-activity relationship established to date. It can be seen that position 1, 2, 5 and 6 of teixobactin are not tolerant of diversion from the native amino acids. In positions 7 and 11, native amino acids give the highest activity but there is tolerance for other amino acids. Positions 3, 4, 9 and 10 are very tolerant of substitution while maintaining good potency and a broad activity spectrum. Activity does not depend on absolute stereochemistry, but on the relative stereochemistry and positions 1, 4, 5, and 8 must contain d-amino acids. The ring and tail structure are necessary for activity, macrolactone and lactam rings are both acceptable. Some teixobactin analogues show greater activity than native teixobactin. All conducted animal studies show positive results with no animal deaths. |
Persistent Identifier | http://hdl.handle.net/10722/284530 |
ISSN | 2023 Impact Factor: 9.4 2023 SCImago Journal Rankings: 1.662 |
ISI Accession Number ID | |
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Matheson, E | - |
dc.contributor.author | JIN, K | - |
dc.contributor.author | Li, X | - |
dc.date.accessioned | 2020-08-07T08:58:57Z | - |
dc.date.available | 2020-08-07T08:58:57Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Chinese Chemical Letters, 2019, v. 30 n. 8, p. 1468-1480 | - |
dc.identifier.issn | 1001-8417 | - |
dc.identifier.uri | http://hdl.handle.net/10722/284530 | - |
dc.description.abstract | In 2015, a new antimicrobial peptide agent was discovered, termed teixobactin. Over the past few years, the structure-activity relationship of teixobactin has been extensively studied. Here, the updated studies have been summarized to provide structure-activity relationship established to date. It can be seen that position 1, 2, 5 and 6 of teixobactin are not tolerant of diversion from the native amino acids. In positions 7 and 11, native amino acids give the highest activity but there is tolerance for other amino acids. Positions 3, 4, 9 and 10 are very tolerant of substitution while maintaining good potency and a broad activity spectrum. Activity does not depend on absolute stereochemistry, but on the relative stereochemistry and positions 1, 4, 5, and 8 must contain d-amino acids. The ring and tail structure are necessary for activity, macrolactone and lactam rings are both acceptable. Some teixobactin analogues show greater activity than native teixobactin. All conducted animal studies show positive results with no animal deaths. | - |
dc.language | eng | - |
dc.publisher | Elsevier Ltd for Chinese Chemical Society. The Journal's web site is located at http://www.chinchemlett.com.cn | - |
dc.relation.ispartof | Chinese Chemical Letters | - |
dc.subject | Teixobactin | - |
dc.subject | Antibacterial | - |
dc.subject | Peptide synthesis | - |
dc.subject | Structure-activity relationship | - |
dc.subject | Cyclic peptides | - |
dc.title | Establishing the structure-activity relationship of teixobactin | - |
dc.type | Article | - |
dc.identifier.email | Li, X: xuechenl@hku.hk | - |
dc.identifier.authority | Li, X=rp00742 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.cclet.2019.07.004 | - |
dc.identifier.scopus | eid_2-s2.0-85069575632 | - |
dc.identifier.hkuros | 311892 | - |
dc.identifier.volume | 30 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | 1468 | - |
dc.identifier.epage | 1480 | - |
dc.identifier.isi | WOS:000482249800003 | - |
dc.publisher.place | China | - |
dc.relation.project | Total Synthesis and Medicinal Chemistry of Cyclic Peptide-based Antibacterial Compounds: An Integrative Programme for Novel Antibiotic Development | - |
dc.identifier.issnl | 1001-8417 | - |